Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.25910/fullpdf
Reference37 articles.
1. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial;Dillman;J Natl Cancer Inst.,1996
2. Significant effect of adjuvant chemotherapy on survival in locally advanced non-small cell lung carcinoma [letter];LeChevalier;J Natl Cancer Inst.,1992
3. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer. Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group;Sause;Chest.,2000
4. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer;Schaake-Konig;N Engl J Med.,1992
5. Concomitant radiochemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients;Auperin;Ann Oncol.,2006
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Radiotherapy and high bilirubin may be metformin like effect on lung cancer via possible AMPK pathway modulation;Bratislava Medical Journal;2022
2. Developing and validating an integrated gross tumor volume (GTV)-TNM stratification system for supplementing unresectable locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy;Radiation Oncology;2020-11-10
3. Clustering of functioning and disability profile based on the WHO disability assessment schedule 2.0 – a nationwide databank study;Disability and Rehabilitation;2020-06-11
4. Treatments of Advanced Non‑Small Cell Lung Cancer (NSCLC) in an Italian Center: Drug Utilization and the Treatment Costs of Innovative Drugs;Farmeconomia. Health economics and therapeutic pathways;2019-03-29
5. Research;Medical Ethics in Clinical Practice;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3